AU2002366713A8 - Nucleotide polymorphisms associated with osteoarthritis - Google Patents
Nucleotide polymorphisms associated with osteoarthritisInfo
- Publication number
- AU2002366713A8 AU2002366713A8 AU2002366713A AU2002366713A AU2002366713A8 AU 2002366713 A8 AU2002366713 A8 AU 2002366713A8 AU 2002366713 A AU2002366713 A AU 2002366713A AU 2002366713 A AU2002366713 A AU 2002366713A AU 2002366713 A8 AU2002366713 A8 AU 2002366713A8
- Authority
- AU
- Australia
- Prior art keywords
- osteoarthritis
- nucleotide polymorphisms
- polymorphisms associated
- nucleotide
- polymorphisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34260301P | 2001-12-20 | 2001-12-20 | |
US60/342,603 | 2001-12-20 | ||
PCT/US2002/041225 WO2003054166A2 (en) | 2001-12-20 | 2002-12-19 | Nucleotide polymorphisms associated with osteoarthritis |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002366713A8 true AU2002366713A8 (en) | 2003-07-09 |
AU2002366713A1 AU2002366713A1 (en) | 2003-07-09 |
Family
ID=23342513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002366713A Abandoned AU2002366713A1 (en) | 2001-12-20 | 2002-12-19 | Nucleotide polymorphisms associated with osteoarthritis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002366713A1 (en) |
WO (1) | WO2003054166A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7198912B2 (en) | 2001-09-07 | 2007-04-03 | Bristol-Myers Squibb Company | Polynucleotides encoding a human G-protein coupled receptor, HGPRBMY39 |
CN1813071A (en) * | 2003-04-29 | 2006-08-02 | 奥克萨根有限公司 | Method of diagnosing a genetic susceptibility for bone damage |
WO2005097421A2 (en) * | 2004-04-01 | 2005-10-20 | Sequenom, Inc. | Methods for identifying risk of osteoarthritis and treatments thereof |
GB0425197D0 (en) * | 2004-11-15 | 2004-12-15 | Ares Trading Sa | Leucine-rich repeat (LRR) motif containing proteins |
AU2006289667A1 (en) * | 2005-09-08 | 2007-03-15 | Apollo Life Sciences Limited | Noggin and chimeric molecules thereof |
FR2908654B1 (en) * | 2006-11-20 | 2014-04-04 | Oreal | COSMETIC USE OF CHITINASE PROTEINS |
CA2690685A1 (en) * | 2007-06-20 | 2008-12-24 | Galapagos N.V. | Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases |
AU2009207922B2 (en) | 2008-01-23 | 2015-05-14 | Herlev Hospital | YKL-40 as a general marker for non-specific disease |
NZ592241A (en) | 2008-09-15 | 2012-11-30 | Herlev Hospital | Ykl-40 as a marker for gastrointestinal cancers |
WO2013082308A1 (en) * | 2011-11-30 | 2013-06-06 | Children's Hospital Medical Center | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support |
HRP20211563T1 (en) | 2013-07-11 | 2022-01-07 | Modernatx, Inc. | Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use |
WO2015127379A1 (en) | 2014-02-24 | 2015-08-27 | Children's Hospital Medical Center | Methods and compositions for personalized pain management |
US11618924B2 (en) | 2017-01-20 | 2023-04-04 | Children's Hospital Medical Center | Methods and compositions relating to OPRM1 DNA methylation for personalized pain management |
CN111088369B (en) * | 2020-01-17 | 2022-11-15 | 天津奥群牧业有限公司 | Detection method, primer pair and application of sheep RORA gene insertion/deletion polymorphism |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265157B1 (en) * | 1991-12-03 | 2001-07-24 | Allegheny University Of The Health Sciences | Compositions and methods for detecting altered COL1A1 gene sequences |
-
2002
- 2002-12-19 AU AU2002366713A patent/AU2002366713A1/en not_active Abandoned
- 2002-12-19 WO PCT/US2002/041225 patent/WO2003054166A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002366713A1 (en) | 2003-07-09 |
WO2003054166A2 (en) | 2003-07-03 |
WO2003054166A3 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1248710A1 (en) | Labelled nucleotides | |
GB0129012D0 (en) | Labelled nucleotides | |
AU2002351077A1 (en) | Oligonucleotides modified with novel alpha-l-rna analogues | |
GB0405884D0 (en) | Modified nucleotides | |
GB0128526D0 (en) | Nucleotide analogues | |
AU2001272482A1 (en) | Osteolevin gene polymorphisms | |
AU2002366713A8 (en) | Nucleotide polymorphisms associated with osteoarthritis | |
AU2001245489A1 (en) | Human single nucleotide polymorphisms | |
AU2002319233A1 (en) | Interferon alpha-14 polymorphism | |
AU2002366709A8 (en) | Nucleotide polymorphisms associated with osteoporosis | |
HU0100131D0 (en) | Novel nucleotide sequences coding for the ptsh-gene | |
AU2002337671A1 (en) | Polymorphisms associated with multiple sclerosis | |
EP1428891A4 (en) | Novel gene nedl-1 | |
GB0111886D0 (en) | Genetic typing | |
AU2002360349A1 (en) | Single nucleotide polymorphisms in gh-1 | |
IL157805A0 (en) | Immobilized oligonucleotides | |
GB0116529D0 (en) | Multi scriber | |
GB0229139D0 (en) | Gene polymorphisms | |
AU2002364894A8 (en) | Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin | |
GB2383044B (en) | Alstroem syndrome gene | |
AU2002214446A1 (en) | Single nucleotide polymorphisms | |
GB0026901D0 (en) | Gene Polymorphisms | |
GB0115225D0 (en) | Nucleotide sequences | |
GB0130116D0 (en) | Gene linkage | |
AU2002249793A1 (en) | Human single nucleotide polymorphisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |